User profiles for Federica Mescia

Federica Mescia

University of Cambridge
Verified email at cam.ac.uk
Cited by 937

[HTML][HTML] Single-cell multi-omics analysis of the immune response in COVID-19

…, A Sanchez-Gonzalez, L Bergamaschi, F Mescia… - Nature medicine, 2021 - nature.com
Abstract Analysis of human blood immune cells provides insights into the coordinated
response to viral infections such as severe acute respiratory syndrome coronavirus 2, which …

[PDF][PDF] Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease

L Bergamaschi, F Mescia, L Turner, AL Hanson… - Immunity, 2021 - cell.com
The kinetics of the immune changes in COVID-19 across severity groups have not been
rigorously assessed. Using immunophenotyping, RNA sequencing, and serum cytokine analysis…

STEC-HUS, atypical HUS and TTP are all diseases of complement activation

M Noris, F Mescia, G Remuzzi - Nature Reviews Nephrology, 2012 - nature.com
Haemolytic uraemic syndrome (HUS) and thrombotic thrombocytopaenic purpura (TTP) are
diseases characterized by microvascular thrombosis, with consequent thrombocytopaenia, …

Analysis of the B cell receptor repertoire in six immune-mediated diseases

…, L Bergamaschi, EF McKinney, DC Pombal, F Mescia… - Nature, 2019 - nature.com
B cells are important in the pathogenesis of many, and perhaps all, immune-mediated diseases.
Each B cell expresses a single B cell receptor (BCR) 1 , and the diverse range of BCRs …

[PDF][PDF] Combined point-of-care nucleic acid and antibody testing for SARS-CoV-2 following emergence of D614G spike variant

…, X Xiong, JAG Briggs, JA Nathan, F Mescia… - Cell Reports …, 2020 - cell.com
Rapid COVID-19 diagnosis in the hospital is essential, although this is complicated by 30%–50%
of nose/throat swabs being negative by SARS-CoV-2 nucleic acid amplification testing (…

[HTML][HTML] A patient-centric modeling framework captures recovery from SARS-CoV-2 infection

…, N Gray, TH Nolan, L Bergamaschi, F Mescia… - Nature …, 2023 - nature.com
The biology driving individual patient responses to severe acute respiratory syndrome
coronavirus 2 infection remains ill understood. Here, we developed a patient-centric framework …

[HTML][HTML] Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups

L Hurler, Á Szilágyi, F Mescia, L Bergamaschi… - Frontiers in …, 2023 - frontiersin.org
Introduction While complement is a contributor to disease severity in severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infections, all three complement pathways might …

[PDF][PDF] SARS-CoV-2 spike N-terminal domain modulates TMPRSS2-dependent viral entry and fusogenicity

…, E Jones, E Legchenko, C Matara, J Martin, F Mescia… - Cell Reports, 2022 - cell.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike N-terminal domain
(NTD) remains poorly characterized despite enrichment of mutations in this region across …

[PDF][PDF] B cell receptor repertoire kinetics after SARS-CoV-2 infection and vaccination

P Kotagiri, F Mescia, WM Rae, L Bergamaschi… - Cell reports, 2022 - cell.com
B cells are important in immunity to both severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
infection and vaccination, but B cell receptor (BCR) repertoire development in …

[PDF][PDF] Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity

…, A Fletcher-Etherington, K Nightingale, F Mescia… - Cell Reports, 2023 - cell.com
Certain serum proteins, including C-reactive protein (CRP) and D-dimer, have prognostic
value in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). …